FDA NDC Directory · JSON-LD · Markdown

glycopyrrolate

NDC 71839-123 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBE Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211705
Dosage form / routeINJECTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsGLYCOPYRROLATE (.2 mg/mL)
Marketing started20220310
Package count1

External sources

Source: openFDA. Public-domain (CC0).